[The evaluation of an instrument for pediatric oncology patient classification]

Sandra de Andrade1, Sérgio Vicente Serrano, Maria Salete de A Nascimento

  • 1Hospital de Câncer de Barretos, Barretos, SP, Brasil. pediatriaint@hcancerbarretos.com.br

Insights

This study evaluated a patient classification instrument for pediatric cancer patients, finding it reliable and reproducible. Minor adjustments are recommended to better suit the specific needs of pediatric oncology patients.

Area of Science:

  • Pediatric Oncology
  • Healthcare Quality Improvement
  • Clinical Classification Systems

Background:

  • Accurate patient classification is crucial for effective care delivery in pediatric oncology.
  • Existing instruments may require validation and adaptation for specific patient populations.
  • Ensuring reproducibility and adequacy of classification tools enhances healthcare quality.

Purpose of the Study:

  • To assess the interrater reproducibility of a patient classification instrument in pediatric cancer patients.
  • To verify the adequacy of the instrument for classifying pediatric oncology patients.
  • To propose modifications for improved suitability in pediatric oncology.

Main Methods:

  • A total of 34 pediatric inpatients at a Cancer Hospital were evaluated.
  • Classification was performed by interdisciplinary teams including physicians, nurses, and nursing technicians.
  • The Kappa coefficient was employed to measure interrater agreement.

Main Results:

  • The Kappa coefficient indicated moderate to high agreement for objective classification items.
  • Low agreement was observed for subjective classification items.
  • The instrument demonstrated reliability and reproducibility.

Conclusions:

  • The patient classification instrument is reliable and reproducible for pediatric cancer patients.
  • Enhancements to specific items are suggested for better alignment with pediatric oncology patient realities.
  • Adaptation of the instrument can improve its utility in specialized pediatric oncology settings.